NM_001370259.2:c.133G>C

Variant summary

Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong

The NM_001370259.2(MEN1):​c.133G>C​(p.Glu45Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E45G) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 30)

Consequence

MEN1
NM_001370259.2 missense

Scores

11
7

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 3.58

Publications

0 publications found
Variant links:
Genes affected
MEN1 (HGNC:7010): (menin 1) This gene encodes menin, a tumor suppressor associated with a syndrome known as multiple endocrine neoplasia type 1. Menin is a scaffold protein that functions in histone modification and epigenetic gene regulation. It is thought to regulate several pathways and processes by altering chromatin structure through the modification of histones. [provided by RefSeq, May 2019]
MEN1 Gene-Disease associations (from GenCC):
  • multiple endocrine neoplasia type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet, Ambry Genetics
  • familial isolated hyperparathyroidism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pituitary gigantism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 19 ACMG points.

PM1
In a hotspot region, there are 12 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 23 uncertain in NM_001370259.2
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-64809976-T-C is described in ClinVar as Pathogenic. ClinVar VariationId is 643100.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in the MEN1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 113 curated pathogenic missense variants (we use a threshold of 10). The gene has 20 curated benign missense variants. Trascript score misZ: 4.1921 (above the threshold of 3.09). GenCC associations: The gene is linked to multiple endocrine neoplasia type 1, hereditary pheochromocytoma-paraganglioma, pituitary gigantism, familial isolated hyperparathyroidism.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.983
PP5
Variant 11-64809977-C-G is Pathogenic according to our data. Variant chr11-64809977-C-G is described in ClinVar as Pathogenic. ClinVar VariationId is 2137154.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001370259.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEN1
NM_001370259.2
MANE Select
c.133G>Cp.Glu45Gln
missense
Exon 2 of 10NP_001357188.2
MEN1
NM_001407150.1
c.133G>Cp.Glu45Gln
missense
Exon 2 of 11NP_001394079.1
MEN1
NM_001370251.2
c.133G>Cp.Glu45Gln
missense
Exon 2 of 11NP_001357180.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEN1
ENST00000450708.7
TSL:5 MANE Select
c.133G>Cp.Glu45Gln
missense
Exon 2 of 10ENSP00000394933.3
MEN1
ENST00000312049.11
TSL:1
c.133G>Cp.Glu45Gln
missense
Exon 2 of 10ENSP00000308975.6
MEN1
ENST00000424912.2
TSL:1
c.133G>Cp.Glu45Gln
missense
Exon 3 of 11ENSP00000388016.2

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
Cov.:
35
GnomAD4 genome
Cov.:
30

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Multiple endocrine neoplasia, type 1 Pathogenic:1
Jun 20, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This missense change has been observed in individuals with clinical features of multiple endocrine neoplasia type 1 (PMID: 15670192, 20530095, 26224587, 29497973; Invitae). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Glu45 amino acid residue in MEN1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12166655, 12746426, 17623761, 29239255). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MEN1 protein function. ClinVar contains an entry for this variant (Variation ID: 2137154). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 45 of the MEN1 protein (p.Glu45Gln).

Hereditary cancer-predisposing syndrome Pathogenic:1
Aug 04, 2025
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.E45Q pathogenic mutation (also known as c.133G>C), located in coding exon 1 of the MEN1 gene, results from a G to C substitution at nucleotide position 133. The glutamic acid at codon 45 is replaced by glutamine, an amino acid with highly similar properties. This variant was reported in individual(s) with features consistent with multiple endocrine neoplasia type 1 (MEN1) (Ellard S et al. Clin Endocrinol (Oxf), 2005 Feb;62:169-75; Occhi G et al. Eur J Endocrinol, 2010 Sep;163:369-76; Marini F et al. Endocrine, 2018 Oct;62:215-233; Ambry internal data). Note, this variant is also referred to as c.243G>C in the literature. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this variant is interpreted as a disease-causing mutation.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.52
D
BayesDel_noAF
Pathogenic
0.51
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.92
D
Eigen
Uncertain
0.55
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.43
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Uncertain
2.6
M
PhyloP100
3.6
PrimateAI
Pathogenic
0.82
D
PROVEAN
Uncertain
-2.4
N
REVEL
Pathogenic
0.88
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.83
P
Vest4
0.81
MutPred
0.97
Loss of helix (P = 0.079)
MVP
1.0
MPC
2.2
ClinPred
0.98
D
GERP RS
3.9
PromoterAI
-0.043
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.88
gMVP
0.94
Mutation Taster
=0/100
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1114167491; hg19: chr11-64577449; API